BC
Birchview Capital’s Cytokinetics CYTK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $330K | Hold |
10,000
| – | – | 0.33% | 50 |
|
2025
Q1 | $402K | Hold |
10,000
| – | – | 0.35% | 37 |
|
2024
Q4 | $470K | Hold |
10,000
| – | – | 0.38% | 35 |
|
2024
Q3 | $528K | Hold |
10,000
| – | – | 0.46% | 29 |
|
2024
Q2 | $542K | Hold |
10,000
| – | – | 0.5% | 30 |
|
2024
Q1 | $701K | Sell |
10,000
-15,000
| -60% | -$1.05M | 0.57% | 30 |
|
2023
Q4 | $2.09M | Hold |
25,000
| – | – | 1.63% | 12 |
|
2023
Q3 | $737K | Hold |
25,000
| – | – | 0.63% | 27 |
|
2023
Q2 | $816K | Hold |
25,000
| – | – | 0.61% | 29 |
|
2023
Q1 | $880K | Hold |
25,000
| – | – | 0.69% | 22 |
|
2022
Q4 | $1.15M | Hold |
25,000
| – | – | 0.81% | 19 |
|
2022
Q3 | $1.21M | Hold |
25,000
| – | – | 0.85% | 23 |
|
2022
Q2 | $982K | Hold |
25,000
| – | – | 0.71% | 22 |
|
2022
Q1 | $920K | Hold |
25,000
| – | – | 0.66% | 28 |
|
2021
Q4 | $1.14M | Hold |
25,000
| – | – | 0.74% | 27 |
|
2021
Q3 | $894K | Buy |
25,000
+15,000
| +150% | +$536K | 0.61% | 30 |
|
2021
Q2 | $198K | Buy |
+10,000
| New | +$198K | 0.12% | 59 |
|
2019
Q4 | – | Sell |
-10,000
| Closed | -$114K | – | 53 |
|
2019
Q3 | $114K | Hold |
10,000
| – | – | 0.08% | 43 |
|
2019
Q2 | $113K | Hold |
10,000
| – | – | 0.07% | 49 |
|
2019
Q1 | $81K | Hold |
10,000
| – | – | 0.05% | 51 |
|
2018
Q4 | $63K | Hold |
10,000
| – | – | 0.06% | 50 |
|
2018
Q3 | $99K | Hold |
10,000
| – | – | 0.06% | 51 |
|
2018
Q2 | $83K | Hold |
10,000
| – | – | 0.06% | 52 |
|
2018
Q1 | $72K | Hold |
10,000
| – | – | 0.05% | 48 |
|
2017
Q4 | $82K | Hold |
10,000
| – | – | 0.05% | 40 |
|
2017
Q3 | $145K | Buy |
+10,000
| New | +$145K | 0.07% | 37 |
|